Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for Urinary Incontinence in Korean Patients
NCT02601287Phase 4Completed
- Sponsor
- Allergan
- Start
- Nov 2015
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of onabotulinumtoxinA in urinary incontinence (UI), overactive bladder (OAB), neurogenic detrusor overactivity (NDO), sponsored by Allergan. Started Nov 2015; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
urinary incontinence (UI)overactive bladder (OAB)neurogenic detrusor overactivity (NDO)
Beyond the preview
Go deeper on NCT02601287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02601287.